As the Coronavirus pandemic continues, many local biomedical and health care companies are rapidly turning their businesses toward fighting COVID-19. Some of these companies have made their focus the immediate need for testing while others are working on a longer time frame with an eye toward potential treatments. Then there are businesses that have changed gears to support the physical side of the battle, trying to develop protective gear and essential devices.
“For the most part, companies are taking existing projects they’ve been working on and are pivoting them toward Coronavirus applications,” said Ahmed Enany, chief executive of the Southern California Biomedical Council, a downtown-based trade group that has been coordinating efforts among local biomedical companies to develop countermeasures against the Coronavirus.
Enany said the pivots came about quickly. “As COVID-19 continued to spread, people were initially weighing the options on whether to jump in, but things got very serious after the lock downs started in mid-March,” he said. Among the local companies that have taken up the challenge to develop, distribute and process rapid-testing kits are OmniPathology Solutions Medical Corp. of Pasadena, Fulgent Genetics Inc. of Temple City, Proactive Diagnostics Inc. of Thousand Oaks, DxTerity Diagnostics Inc. of Rancho Dominguez and MiraDX Inc. of West Los Angeles.